We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

601009:SSEBank of Nanjing Co., Ltd. Class A Analysis

Data as of 2026-06-14 - not real-time

CN¥11.83

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Bank of Nanjing is trading at CNY 11.83, hugging its recent resistance level while comfortably above its 20‑day (CNY 11.12) and 200‑day (CNY 11.22) moving averages, indicating short‑term momentum. The RSI of 68.9 suggests strong buying pressure yet remains just below the overbought threshold, and a bullish MACD histogram (+0.10) reinforces the upside bias. Market sentiment is extremely optimistic, reflected by a Fear & Greed Index of 89.86 (Extreme Greed), and trading volume is on the rise, supporting liquidity.
Fundamentally, the bank appears deeply undervalued: a trailing P/E of 6.9 versus the industry average of 16.8, a P/B of 0.78, and a DCF‑derived fair value near CNY 125 point to a sizable valuation gap. Profitability is solid with an operating margin of 68.9% and ROE of 10.9%, while revenue is growing at 5.7% YoY. The dividend yield of 4.47% coupled with a modest payout ratio (29.6%) signals sustainable income, and a near‑zero beta (0.11) underscores low market‑wide volatility despite a 30‑day price volatility of about 20%.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price at resistance with high RSI
  • Bullish MACD but approaching overbought levels
  • Increasing volume supports short‑term stability

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Significant valuation discount (P/E 6.9 vs 16.8 industry)
  • Strong dividend yield and low payout ratio
  • Stable earnings and low systematic risk (beta 0.11)

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Robust profitability and consistent revenue growth
  • Sustainable dividend policy providing steady cash flow
  • Long‑term undervaluation indicated by DCF fair value

Key Metrics & Analysis

Financial Health

Revenue Growth5.70%
Profit Margin53.00%
P/E Ratio6.9
ROE10.92%
ROA0.75%
P/B Ratio0.8
Op. Cash FlowCN¥142.7B
Industry P/E16.8

Technical Analysis

TrendNeutral
RSI68.9
SupportCN¥10.59
ResistanceCN¥11.83
MA 20CN¥11.11
MA 50CN¥11.24
MA 200CN¥11.22
MACDBullish
VolumeIncreasing
Fear & Greed Index89.86

Valuation

Fair ValueCN¥124.99
GradeUndervalued
TypeValue
Dividend Yield4.47%

Risk Assessment

Beta0.00
Volatility20.01%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.